Asterix Foods
Israel
- Tel Aviv
- 10/10/2025
- Seed
- $4,200,000
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins.
Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
- Industry Biotechnology
- Website https://www.asterixfoods.com/
- LinkedIn https://www.linkedin.com/company/asterix-foods/
Related People
Dan EvenFounder
Israel -
Tel Aviv District
Experienced in Molecular Biology, Plant Genetic Engineering, and Plant Biology.
Specializing in: Research and Development, Biotechnology, Molecular Biology, Alternative Food & Protein, Plant Biology, Plant Genetic Engineering, Protein Purification & Expression, Antibody Engineering, Microbiology.
Vor Systems | $3,000,000 | (Mar 6, 2026)
IntelliGRC | $3,500,000 | (Mar 6, 2026)
Cyclops | $8,000,000 | (Mar 6, 2026)
Lio (formerly askLio) | $30,000,000 | (Mar 6, 2026)
Navigara | $2,500,000 | (Mar 6, 2026)
AgriPass | $7,500,000 | (Mar 6, 2026)
Reclaim Security | $20,000,000 | (Mar 6, 2026)
NextWork | $4,450,000 | (Mar 6, 2026)
Vast | $500,000,000 | (Mar 6, 2026)
Qura | $1,739,595 | (Mar 4, 2026)
Escargot | $2,750,000 | (Mar 4, 2026)
Worldscape | Undisclosed Amount | (Mar 4, 2026)